Cardiol Therapeutics (CRDL) Competitors C$1.95 +0.04 (+2.09%) (As of 12/17/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades CRDL vs. DNA, VBV, CUS, AIM, FRX, APM, IPA, ITH, MDNA, and GXEShould you be buying Cardiol Therapeutics stock or one of its competitors? The main competitors of Cardiol Therapeutics include Dalradian Resources (DNA), VBI Vaccines (VBV), Chemtrade Electrochem Inc, (CUS), Aimia (AIM), Fennec Pharmaceuticals (FRX), Andean Precious Metals (APM), ImmunoPrecise Antibodies (IPA), International Tower Hill Mines (ITH), Medicenna Therapeutics (MDNA), and Gear Energy (GXE). These companies are all part of the "pharmaceutical products" industry. Cardiol Therapeutics vs. Dalradian Resources VBI Vaccines Chemtrade Electrochem Inc, Aimia Fennec Pharmaceuticals Andean Precious Metals ImmunoPrecise Antibodies International Tower Hill Mines Medicenna Therapeutics Gear Energy Cardiol Therapeutics (TSE:CRDL) and Dalradian Resources (TSE:DNA) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, community ranking, earnings, analyst recommendations, institutional ownership, profitability, dividends, risk and media sentiment. Do insiders and institutionals have more ownership in CRDL or DNA? 11.4% of Cardiol Therapeutics shares are owned by institutional investors. 4.6% of Cardiol Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Do analysts recommend CRDL or DNA? Given Dalradian Resources' higher probable upside, analysts plainly believe Dalradian Resources is more favorable than Cardiol Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cardiol Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Dalradian Resources 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community believe in CRDL or DNA? Dalradian Resources received 196 more outperform votes than Cardiol Therapeutics when rated by MarketBeat users. However, 69.23% of users gave Cardiol Therapeutics an outperform vote while only 66.78% of users gave Dalradian Resources an outperform vote. CompanyUnderperformOutperformCardiol TherapeuticsOutperform Votes969.23% Underperform Votes430.77% Dalradian ResourcesOutperform Votes20566.78% Underperform Votes10233.22% Which has preferable earnings & valuation, CRDL or DNA? Cardiol Therapeutics is trading at a lower price-to-earnings ratio than Dalradian Resources, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCardiol TherapeuticsN/AN/A-C$29.34M-C$0.44-4.43Dalradian ResourcesN/AN/AN/A-C$0.03N/A Does the media favor CRDL or DNA? In the previous week, Cardiol Therapeutics had 6 more articles in the media than Dalradian Resources. MarketBeat recorded 6 mentions for Cardiol Therapeutics and 0 mentions for Dalradian Resources. Cardiol Therapeutics' average media sentiment score of 0.00 equaled Dalradian Resources'average media sentiment score. Company Overall Sentiment Cardiol Therapeutics Neutral Dalradian Resources Neutral Is CRDL or DNA more profitable? Dalradian Resources' return on equity of 0.00% beat Cardiol Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Cardiol TherapeuticsN/A -108.43% -54.15% Dalradian Resources N/A N/A N/A SummaryCardiol Therapeutics beats Dalradian Resources on 7 of the 12 factors compared between the two stocks. Ad Crypto 101 MediaThis Crypto Is Set to Explode in DecemberDiscover our #1 crypto for the Trump Presidency Bull Run now! (Available for a Short Time) We highly recommend this hot altcoin before prices get too high Check it out by going here now Get Cardiol Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRDL vs. The Competition Export to ExcelMetricCardiol TherapeuticsDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$136.27MC$1.17BC$5.19BC$5.47BDividend YieldN/A3.07%4.78%5.73%P/E Ratio-4.43112.22128.2227.77Price / SalesN/A2,563.901,259.001,225.62Price / Cash0.989.9241.2276.62Price / Book8.863.054.883.80Net Income-C$29.34MC$152.73MC$119.69MC$290.82M7 Day Performance-3.94%-1.01%16.64%-2.09%1 Month Performance-22.62%-1.75%16.32%1.91%1 Year Performance77.27%107.13%35.37%35.99% Cardiol Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRDLCardiol TherapeuticsN/AC$1.95+2.1%N/A+69.6%C$136.27MN/A-4.4320News CoverageDNADalradian ResourcesN/AC$1.46-0.7%N/AN/AC$519.02MN/A-56.15640VBVVBI VaccinesN/AC$4.82-5.1%N/AN/AC$308.86MC$3.36M-4.9722CUSChemtrade Electrochem Inc,N/AC$1.64-0.6%N/AN/AC$306.50MN/A0.0060News CoverageAIMAimia2.1778 of 5 starsC$2.66-1.8%C$4.00+50.4%-14.6%C$261.69MC$396.20M-2.0420News CoverageFRXFennec PharmaceuticalsN/AC$8.51-2.0%N/A-34.8%C$232.83MC$48.89M85.1010APMAndean Precious Metals1.7207 of 5 starsC$1.32-3.6%C$1.70+28.8%N/AC$197.16MC$199.84M3.6130IPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080Gap DownITHInternational Tower Hill MinesN/AC$0.69-4.2%N/A+2.9%C$137.79MN/A-23.00220News CoverageMDNAMedicenna TherapeuticsN/AC$1.72-2.8%N/A+297.8%C$131.46MN/A-4.6620GXEGear Energy3.4974 of 5 starsC$0.48flatC$1.00+108.3%-29.5%C$126.52MC$134.93M9.601,310Dividend Announcement Related Companies and Tools Related Companies Dalradian Resources Alternatives VBI Vaccines Alternatives Chemtrade Electrochem Inc, Alternatives Aimia Alternatives Fennec Pharmaceuticals Alternatives Andean Precious Metals Alternatives ImmunoPrecise Antibodies Alternatives International Tower Hill Mines Alternatives Medicenna Therapeutics Alternatives Gear Energy Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:CRDL) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiol Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
